Eighteen states and the District of Columbia sued the Trump administration late Friday over its decision to halt billions of dollars in Affordable Care Act subsidies, saying the sudden move wasn’t explained properly and unconstitutionally disregarded mandatory spending.
The Massachusetts Senate on Thursday unanimously voted to ban bump stocks and trigger cranks, which allow users to modify semiautomatic guns into fully automatic ones, following the deadly mass shooting in Las Vegas earlier this month.
Seven states and several other groups on Thursday urged the D.C. Circuit to reject a truck trailer manufacturers’ association's bid to delay implementation of a federal rule aimed at reducing greenhouse gas emissions from heavy-duty truck trailers, saying that the trailer makers won’t suffer irreparable harm.
A Massachusetts clothing and sports retailer filed suit in federal court Thursday alleging that financial technology company Kabbage Inc. evaded state law by offering high-interest loans through an industrial bank based in Utah, which places no ceiling on interest rates for commercial loans, all the while serving as the true lender.
Executives at Insulet Corp., a manufacturer of insulin pumps, misrepresented the success of a new-product rollout, ultimately causing shares of the company to plunge, a shareholder claimed in a derivative suit filed Friday in Massachusetts federal court.
California Gov. Jerry Brown's signing Thursday of a new law barring employers from asking job applicants about their salary histories is the latest of several newly adopted state and local laws banning such inquiries that businesses will soon have to follow. Here, Law360 answers a few of employers’ most pressing questions about the bans.
Several companies and firms have bolstered their health and life sciences practices over the last few weeks, including Boston Scientific Corp., which named a new general counsel with a wealth of in-house experience, and Mintz Levin, which expanded its health practice with the former general counsel of a major New England health system.
Boston-based Auctus Private Equity Fund LLC filed lawsuits against two companies in Massachusetts federal court on Wednesday, accusing both of breaches of contract involving default events that affected the fund’s securities purchase agreements with them.
Shares of Cargurus Inc. rallied upon debut on Thursday, one day after the online automotive marketplace priced its initial public offering above forecasted range and raised $150.4 million, representing the largest of three IPOs that generated $227 million total.
A Dimension Therapeutics Inc. shareholder urged a Massachusetts federal court Wednesday to block Ultragenyx Pharmaceutical Inc.’s proposed $151 million acquisition of the company, alleging Dimension withheld material information from the U.S. Securities and Exchange Commission and is undercutting investors’ share of the profits.
A potential class of eyedrops users alleging generic-drug makers such as Sandoz Inc. boosted prescription sales by using bottles that dispensed larger-than-needed drops told the Third Circuit Wednesday that a suit tossed in Massachusetts shouldn't end theirs.
The Centers for Medicare & Medicaid Services has urged the First Circuit to reverse a lower court’s ruling in favor of hospitals that have accused the agency of unlawfully instituting a “clarification” that alters a Medicaid reimbursement policy so the hospitals are paid less.
The First Circuit refused Wednesday to reconsider its August decision upholding the dismissal of a putative securities class action accusing drugmaker Sarepta Therapeutics Inc. of misleading investors over the possibility of government approval for its muscular dystrophy drug eteplirsen.
Three pharmaceutical companies involved in a $1 billion patent infringement suit over a quality control test for a generic blood thinner contested each other’s dueling bids for post-trial relief Wednesday — including judgment or a new trial — after a jury found the patent was infringed but the claims were nonetheless invalid.
A retired Army colonel pled not guilty in Boston federal court Thursday to charges that he conspired to help bribe Haitian officials to secure approvals for an $84 million port project.
A Boston judge decided Thursday to release a former pharmaceutical executive accused of insider trading while he awaits trial despite the court's concerns that the defendant’s “Dr. Jekyll and Mr. Hyde” tendencies might reappear.
Boston’s pro-immigrant stance has earned it the label of “sanctuary city,” but it isn’t involved in litigation over sanctuary city funding threats, and has to contend with a Republican governor who takes a more hard-line approach to immigration. Here’s where Boston stands on several sanctuary city issues.
Royal Philips’ North American unit has agreed to stop making external defibrillators at two facilities in Washington and Massachusetts until the U.S. Food and Drug Administration confirms that the locations comply with good manufacturing practices, the company said Wednesday.
A fishing industry giant known as "The Codfather” was ordered by a Massachusetts federal court on Wednesday to forfeit four boats and 34 fishing licenses worth roughly $2.3 million, just weeks after he was sentenced to nearly four years in prison for evading taxes and fish quotas.
A Massachusetts state jury awarded $4 million in a suit accusing doctors of failing to provide a 36-year-old woman with proper medical care, which caused her death shortly after she gave birth to a healthy child, the family’s attorney said.
True pharmaceutical innovation that results in improved clinical outcomes may be cost-increasing in terms of budget impact, while still providing great value in terms of cost effectiveness. Massachusetts policies should find ways to pay for the pharmaceutical innovation instead of forcing manufacturers to accept lower prices for cost-effective innovations, says Noam Kirson of Analysis Group Inc.
The Sedona Conference Working Group's updated Sedona Principles provides a timely reminder that the legal industry needs to be thinking more seriously about the interconnectedness between e-discovery and information governance, says Saffa Sleet of FTI Consulting Inc.
If Superstorm Sandy had coincided with Boston’s high tide by a mere five hours, many neighborhoods in Boston and Cambridge would have flooded. As we approach the fifth anniversary of Superstorm Sandy and reflect on the devastating impacts of recent hurricanes, it is critical to understand what would have happened if one of those storms had taken a slightly different route, says Ruth Silman, managing partner of Nixon Peabody LLP's Boston office.
Albert Einstein famously said, “The definition of insanity is doing the same thing over and over again, but expecting different results.” That maxim applies to large companies that seek more value and diversity from their outside counsel by expecting big firms to change. There’s a simple solution to this problem, according to attorneys Margaret Cassidy, Sara Kropf and Ellen D. Marcus.
The recent enactment of laws permitting the cultivation and sale of recreational marijuana in Massachusetts commencing in July 2018 have created great opportunities for real estate owners and developers, and also great risks. By including certain provisions in their leases, landlords can at least mitigate many of those risks, says William Moorman Jr. of Patridge Snow & Hahn LLP.
Looking at academic research and the impact of marijuana legalization on opioid use, adolescent marijuana use and crime in other states may hint at what effects recent changes in Massachusetts' marijuana laws will have, say analysts with Analysis Group Inc.
When venue is challenged, who bears the burden of proof in patent cases? It turns out the courts are sharply divided on this important issue, say attorneys with Mayer Brown LLP.
Digital health is now an accepted part of the health care delivery system and has been widely adopted by both health providers and consumers. However, technology is evolving quickly and counsel for businesses entering this market in Massachusetts must keep up with a complex legal and regulatory landscape, says Ellen Janos of Mintz Levin Cohn Ferris Glovsky and Popeo PC.
Payment collection delays have caused law firms to seek new options, one of which is litigation finance. In this context, litigation finance can offer alternative avenues to firms as they approach the end of a fiscal year or partnership distribution dates, says Travis Lenkner of Burford Capital LLC.
Massachusetts employers may appreciate a short, unpublished opinion that the Massachusetts Appeals Court issued this summer because it underscores yet again the importance of the conditional privilege that generally is available to protect employers from employee defamation claims, says David Henderson, a partner with Nutter McClennen & Fish LLP.